We are going to be punished.

Discussion in 'Alcon' started by anonymous, Oct 25, 2016 at 8:33 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    So based on the quarterly report today, I am hearing Novartis puts the blame squarely on Alcon. No raises and no bonuses in the works or 2017. Novartis of course cannot admit they are the ones that screwed us up, and now punish us for what they did.
     

  2. anonymous

    anonymous Guest

     
  3. anonymous

    anonymous Guest

    This poor performance will continue until Novartis sells us to Allergan
     
  4. anonymous

    anonymous Guest

    We are taking over.

    RLo, RB
     
  5. anonymous

    anonymous Guest

    Allergan isn't interested in buying Alcon.
     
  6. anonymous

    anonymous Guest

    Then who? It's gonna be someone and soon
     
  7. anonymous

    anonymous Guest

    Notice how JJ spent most of his time talking up the future of Pharma, nothing about surgical.
     
  8. anonymous

    anonymous Guest

    Exactly
     
  9. anonymous

    anonymous Guest

    Nobody at Novartis knows a damn thing about Surgical.
     
  10. anonymous

    anonymous Guest

    We are doomed!
     
  11. anonymous

    anonymous Guest

     
  12. anonymous

    anonymous Guest

    Jan 2017
     
  13. anonymous

    anonymous Guest

     
  14. anonymous

    anonymous Guest

    Earnings?
     
  15. anonymous

    anonymous Guest

    We won't make our target, but be told that everything is still on the up and up. Meanwhile Novartis will blame their earnings on Alcon at the next shareholders' meeting. Rinse and repeat every quarter.